Details of the Drug

General Information of Drug (ID: DM8CLG2)

Drug Name

Sodium orthovanadate

Synonyms

13721-39-6; Trisodium vanadate; Sodium pervanadate; Sodium o-vanadate; Sodium vanadate (ortho); Trisodium tetraoxovanadate; Sodium tetraoxovanadate(3-); Vanadic acid, trisodium salt; TRISODIUM ORTHOVANADATE; Vanadic acid (H3VO4), sodium salt; UNII-7845MV6C8V; trisodium trioxido(oxo)vanadium; CCRIS 9063; Vanadic(II) acid, trisodium salt; EINECS 237-287-9; NSC 79534; Vanadate (VO43-), trisodium, (T-4)-; AI3-52157; Vanadate(VO4(3-)), trisodium; CHEBI:35607; 7845MV6C8V; Vanadic (II) Acid, Trisodium

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski):
0

Molecular Weight

183.908

Logarithm of the Partition Coefficient

Not Available

Rotatable Bond Count

Hydrogen Bond Donor Count

Hydrogen Bond Acceptor Count

Chemical Identifiers

Formula: Na3O4V
IUPAC Name: trisodium;trioxido(oxo)vanadium
Canonical SMILES: [O-][V](=O)([O-])[O-].[Na+].[Na+].[Na+]
InChI: InChI=1S/3Na.4O.V/q3*+1;;3*-1;
InChIKey: IHIXIJGXTJIKRB-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 61671
ChEBI ID: CHEBI:35607
CAS Number: 13721-39-6
TTD ID: D0C6RO

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Protein tyrosine phosphatase IVA 3 (PRL-3)	TT7YM8D	TP4A3_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Lett. 2004 May 7;565(1-3):181-7.